Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fez family zinc finger protein 1 (FEZF1)
- Target
- FEZF1
- Molecular classification
- Transcription factor, Zinc finger protein
01
Overview
Fez family zinc finger protein 1 (FEZF1) is a transcription factor containing C2H2-type zinc fingers, encoded by the FEZF1 gene. It is highly conserved across vertebrates and is critical for proper neural development, including forebrain patterning, differentiation of neural stem cells, olfactory sensory neuron maturation, and migration of gonadotropin-releasing hormone (GnRH) neurons. FEZF1 acts as a transcriptional repressor and activator, modulating genes such as Hes5 to promote neurogenesis and activating Wnt signaling pathway targets to enhance cell proliferation, growth, and migration in cancer cells. Aberrant FEZF1 expression has been implicated in several cancers—including cervical, gastric, and colorectal cancers—where it may promote malignant progression. Mutations or dysregulation of FEZF1 are involved in neurodevelopmental syndromes such as Kallmann syndrome, with loss of function resulting in impaired forebrain segmentation and GnRH neuron migration deficits.
- Other names
- FEZ family zinc finger 1FEZF1FEZZNF312BZinc finger protein 312BHH22
02
Mechanism of action
No approved drugs; but inhibition of FEZF1 reduces malignant cell proliferation and migration by suppressing activation of the Wnt pathway and oncogenic targets.
03
Biological functions
Neural stem cell differentiationNeurogenesis, especially in forebrain developmentDivision and patterning of thalamic and prethalamic regionsSensory neuron identity and olfactory developmentCell proliferation, migration, and growth (in cancer)Transcriptional repression of neural inhibitory genes (e.g., Hes5)Activation of Wnt signaling pathway genes in cancer cells
04
Disease associations
Cancer (cervical, gastric, colorectal)Neurodevelopmental disorders (e.g., Kallmann syndrome)Other: Possible role in hypothalamic-pituitary-gonadal axis defects (via GnRH neuron migration)
05
Safety considerations
Targeting FEZF1 for therapy could affect fundamental neurodevelopmental processes and olfactory/neuronal identityRisk of off-target neurological or endocrine side effects due to its essential developmental roles
06
Biomarkers
FEZF1 overexpression as a marker for recurrence risk in cervical cancerFEZF1 levels as a potential marker for neurodevelopmental defects (Kallmann syndrome)
Beyond the preview
Go deeper on Fez family zinc finger protein 1 (FEZF1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fez family zinc finger protein 1 (FEZF1).